<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The aim of this study was to review some prognostic factors for survival after radiofrequency ablation (RFA) of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: From 1996 to 2009, 262 patients with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were treated with RFA </plain></SENT>
<SENT sid="2" pm="."><plain>Fourteen were lost to follow-up </plain></SENT>
<SENT sid="3" pm="."><plain>The following predictors were analysed in the remaining 248: synchronous/metachronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, single/multiple <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, diameter of largest <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and absence/presence of extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Survival was measured from the date of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> diagnosis and from the date of RFA </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Survival at 1, 2, 3 and 5 years was 93%, 78%, 62% and 35% from <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> diagnosis, and 84%, 59%, 43% and 23% from the date of RFA </plain></SENT>
<SENT sid="6" pm="."><plain>Median survival was 41 months in patients with largest <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> ≤3 cm and 21.7 months for those with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> &gt;3 cm (p=0.0001); survival increased to 45.2 months in patients with largest <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> ≤2.5 cm and fell to 18.5 months in those with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> &gt;3.5 cm </plain></SENT>
<SENT sid="7" pm="."><plain>Median survival of patients with extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> was significantly lower than that of patients without extrahepatic disease (23.3 vs. 32.6 months, p=0.018) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In light of our long-term results obtained with commonly used equipment, small lesion size (diameter of largest lesion ≤3 or 2.5 cm) proved to be the most favourable prognostic factor for survival in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> to the liver treated with RFA </plain></SENT>
<SENT sid="9" pm="."><plain>This conclusion is probably related to the possibility of obtaining radical ablation and points to the usefulness of devices allowing ablation of larger volumes </plain></SENT>
<SENT sid="10" pm="."><plain>In the presence of extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, RFA has less impact on survival, even though it is potentially useful in patients at a higher risk of <z:hpo ids='HP_0011420'>death</z:hpo> due to hepatic rather than extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
</text></document>